Commission Implementing Regulation (EU) 2026/2517 of 12 November 2026 concerning the non-renewal of the approval of the active substance buprofezin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011

Commission Implementing Regulation (EU) 2026/2517 of 12 November 2026 concerning the non-renewal of the approval of the active substance buprofezin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011

Citenza

Inteligencia jurídica con fuentes verificables, por Datons.

citenza.io